Related Experiment Video

Updated: Jun 22, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

Ribavirin acts via multiple pathways in inhibition of leukemic cell proliferation

Szabolcs Kökény1, János Papp, George Weber

  • 1National Institute of Oncology, Department of Molecular Genetics, H-1122 Budapest, Hungary.

Anticancer Research
|June 17, 2009
PubMed
Abstract

Insights

Ribavirin, an antiviral drug, shows potent anticancer activity by inhibiting cancer cell growth and inducing apoptosis. It also modulates gene expression related to cell survival and proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Ribavirin is an antiviral medication known to inhibit inositide-5'-monophosphate dehydrogenase.
  • Its potential anticancer effects warrant further investigation.

Purpose of the Study:

  • To investigate the anticancer activity of Ribavirin.
  • To determine its effects on cancer cell growth, apoptosis, and differentiation pathways.
  • To analyze its impact on gene expression in cancer cells.

Main Methods:

  • Human cancer cell lines were used to assess Ribavirin's effects on cell growth and apoptosis.
  • Cytological methods were employed to study apoptotic and differentiation pathways.
  • Quantitative Polymerase Chain Reaction (Q-PCR) was used to analyze gene expression changes in K562 cells.

Main Results:

  • Ribavirin significantly inhibited cancer cell growth with an IC(50) of 15 microM.
  • The drug activated apoptosis and differentiation pathways in K562 cells.
  • Ribavirin modulated the expression of approximately 60 out of 85 genes involved in cell proliferation, purine biosynthesis, translation initiation, oncogenic signaling, and cell survival.

Conclusions:

  • Ribavirin demonstrates potent anticancer properties, acting as a strong inducer of apoptosis and a moderate inducer of differentiation.
  • These anticancer effects are achieved through the modulation of critical molecular and metabolic pathways.
  • Ribavirin holds promise as a therapeutic agent for cancer treatment.

More Related Videos

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...